UBS Group
NBACR

UBS Group’s Newborn Acquisition Corp. Right NBACR Stock Holding History

UBS Group’s Portfolio NBACR Stock Details NBACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,138
Closed -$4K – 9857
2020
Q4 		$4K Buy
3,138
+3,039
+3,070% +$2.48K ﹤0.01% 7967
2020
Q3 		$0 Buy
+99
New +$20 ﹤0.01% 8693

UBS Group's NBACR Position: Q1 2021 in Review

UBS Group sold out of Newborn Acquisition Corp. Right (NBACR) in Q1 2021, closing a stake of 3,138 shares — an estimated $4K sold.

UBS Group first reported a position in NBACR in Q3 2020 and held it in 2 quarters. The position peaked at $4K in Q4 2020. 0 funds tracked by Wall St. Rank hold NBACR as of Q1 2021.

  • UBS Group reported no remaining Newborn Acquisition Corp. Right position as of Q1 2021 after selling out during the quarter.
  • UBS Group sold 3,138 Newborn Acquisition Corp. Right shares in Q1 2021, an estimated $4K.
  • UBS Group first reported a position in Newborn Acquisition Corp. Right in Q3 2020 and held it in 2 quarters.
  • UBS Group's Newborn Acquisition Corp. Right position peaked at $4K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Newborn Acquisition Corp. Right as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.